News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
16,657 Results
Type
Article (1455)
Company Profile (1)
Press Release (15201)
Section
Business (3072)
Career Advice (3)
Deals (460)
Drug Delivery (2)
Drug Development (3426)
FDA (771)
Job Trends (324)
News (7742)
Policy (732)
Tag
Academia (95)
Accelerated approval (2)
Adcomms (3)
Alliances (984)
ALS (4)
Alzheimer's disease (37)
Antibody-drug conjugate (ADC) (1)
Approvals (800)
Artificial intelligence (1)
Autoimmune disease (5)
Automation (2)
Bankruptcy (2)
Best Places to Work (298)
Biosimilars (21)
Biotechnology (2)
Bladder cancer (13)
Brain cancer (2)
Breast cancer (11)
Cancer (107)
Cardiovascular disease (32)
Career advice (3)
CAR-T (4)
Cell therapy (10)
Clinical research (3059)
Collaboration (37)
Complete response letters (5)
COVID-19 (40)
CRISPR (4)
C-suite (15)
Cystic fibrosis (1)
Data (311)
Depression (5)
Diabetes (221)
Diagnostics (126)
Digital health (3)
Drug discovery (3)
Duchenne muscular dystrophy (26)
Earnings (1469)
Events (2059)
Executive appointments (9)
FDA (913)
Funding (30)
Gene editing (5)
Gene therapy (26)
GLP-1 (242)
Government (88)
Guidances (15)
Healthcare (333)
HIV (8)
Huntington's disease (1)
IgA nephropathy (8)
Immunology and inflammation (8)
Indications (7)
Infectious disease (43)
Inflammatory bowel disease (4)
Intellectual property (11)
IPO (222)
Job creations (49)
Job search strategy (3)
Layoffs (8)
Legal (83)
Liver cancer (1)
Longevity (2)
Lung cancer (15)
Lymphoma (8)
Manufacturing (27)
MASH (10)
Medical device (593)
Medtech (594)
Mergers & acquisitions (257)
Metabolic disorders (344)
Neurodegenerative disease (4)
Neuropsychiatric disorders (1)
Neuroscience (97)
NextGen: Class of 2026 (103)
Non-profit (99)
Now hiring (1)
Obesity (119)
Opinion (2)
Ovarian cancer (12)
Pain (1)
Pancreatic cancer (4)
Parkinson's disease (36)
Patents (12)
Patient recruitment (19)
People (664)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (732)
Phase 2 (1263)
Phase 3 (1145)
Pipeline (223)
Policy (1)
Postmarket research (251)
Preclinical (387)
Prostate cancer (5)
Radiopharmaceuticals (2)
Rare diseases (29)
Real estate (50)
Regulatory (761)
Reports (2)
Research institute (81)
Schizophrenia (8)
Series A (7)
Series B (1)
Sickle cell disease (2)
Spinal muscular atrophy (1)
Sponsored (1)
Startups (66)
Stomach cancer (1)
Supply chain (2)
Tariffs (3)
Vaccines (8)
Weight loss (63)
Women's health (2)
Date
Last 7 days (21)
Last 30 days (76)
Last 365 days (937)
2026 (103)
2025 (918)
2024 (1098)
2023 (1039)
2022 (1355)
2021 (1315)
2020 (1132)
2019 (943)
2018 (790)
2017 (813)
2016 (810)
2015 (1023)
2014 (769)
2013 (576)
2012 (584)
2011 (697)
2010 (578)
Location
Africa (8)
Alabama (1)
Arizona (1)
Arkansas (2)
Asia (1233)
Australia (150)
California (339)
Canada (87)
China (53)
Colorado (4)
Connecticut (10)
Delaware (7)
Europe (2599)
Florida (29)
Georgia (3)
Illinois (38)
India (6)
Indiana (37)
Japan (12)
Kentucky (4)
Louisiana (2)
Maine (2)
Maryland (126)
Massachusetts (156)
Michigan (3)
Minnesota (4)
Missouri (2)
Nevada (12)
New Hampshire (3)
New Jersey (126)
New York (87)
North Carolina (46)
Northern California (207)
Ohio (3)
Oregon (12)
Pennsylvania (36)
Puerto Rico (2)
South America (13)
Southern California (123)
Tennessee (3)
Texas (49)
United States (1164)
Utah (2)
Virginia (5)
Washington D.C. (9)
Washington State (43)
Wisconsin (1)
16,657 Results for "gluco chaser".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mpac Lambert Partners with GlucoModicum to Deliver Scalable Automation for Needle-Free Glucose Monitoring Sensor
Mpac Lambert is delivering a fully automated, ultra-high-volume line for GlucoModicum’s needle-free glucose sensor Sofio - providing sub-second cycle time, medical-grade precision, and scalable capacity of 21 million units per year, supported by two years of industrial-scale proof-of-principle work.
January 20, 2026
·
1 min read
Press Releases
GlucoModicum unveils Sofio™, the world’s first needle-free glucose monitor based on magneto-hydrodynamics (MHD)
December 18, 2025
·
2 min read
Press Releases
Hamilton Launches GlucoSense, a First-of-Its-Kind, Real-Time, In Situ Glucose Sensor for Mammalian Cell Culture
December 16, 2025
·
5 min read
BioForest
Gluco-Chaser Releases a Working Prototype for Proprietary Non-Enzymatic Electrochemical Glucose Sensors Claiming a Multitude of Advantages (www.Gluco-Chaser.com).
The Gluco-Chaser offers flexibility in choosing a platform format, cost savings in production and storage (highly affordable end user pricing), and other technical features that improve user comfort level and hygiene.
November 21, 2017
·
2 min read
BioForest
Gluco-Chaser Inc. Announces Disposable Glucose Sensor Results with Non-Enzymatic Electrochemistry
It does not compromise the accuracy of Gluco-Chaser’s proprietary nanoporous sensor technology (Error Grid Analysis A+B 98%; N=100).
February 8, 2018
·
3 min read
Pharm Country
Sun Pharma’s GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions
Sun Pharmaceutical Industries Limited announced results from a Phase 1, multiple ascending-dose study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of GL0034 in obese adults.
June 22, 2024
·
6 min read
Press Releases
Senseonics Receives European Approval for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
January 30, 2026
·
7 min read
Press Releases
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
January 29, 2026
·
4 min read
Press Releases
Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System
January 9, 2026
·
6 min read
Press Releases
Crinetics Announces Strong PALSONIFY Launch Execution and Positive Results for Concurrent Androstenedione Lowering and Glucocorticoid Dose Reduction in Phase 2 Trial of Atumelnant for Congenital Adrenal Hyperplasia
January 5, 2026
·
12 min read
1 of 1,666
Next
